Author： Hanson G.J.
Publisher： Informa Healthcare
ISSN： 1354-3776
Source： Expert Opinion on Therapeutic Patents, Vol.7, Iss.7, 1997-07, pp. : 729-733
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 1, 2000-01 ,pp. :
Access to resources
Recommend
Allosteric p38 kinase inhibitors
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. :
Substituted pyrazoles as p38 kinase inhibitors
Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 7, 1999-07 ,pp. :
The Discovery of Novel Chemotypes of p38 Kinase Inhibitors
Current Topics in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-09 ,pp. :
Pyridinylimidazole Based p38 MAP Kinase Inhibitors
Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. :